Neuron Specific Enolase (NSE)
Back to Test Catalogue
Neuron Specific Enolase (NSE), Serum
Test ID: NSE S
Test
Method
Immunofluorescence Assay (IFA)
Report Includes
Specimens
Serum
Clinical Utility
Quantitative determination of NSE in serum may be valuable in the management of patients with suspected or diagnosed SCLC or neuroblastoma, to monitor the effect of treatment, to aid in the detection of recurrent disease, and to evaluate prognosis in patients.
Test Version
19-Nov-2025
Specimen
Specimens
Serum
Collection Containers
Gold top (clot activator & gel)
Sample Volume
1.0 mL
Minimum Volume
0.3 mL
Stability
| Ambient | 7 days |
|---|---|
| Refrigerated | 7 days |
| Frozen | 30 days |
Rejection Criteria
| Hemolysis | Present |
|---|
Test Version
19-Nov-2025
Performance / Interpretation
Method
Immunofluorescence Assay (IFA)
Turnaround Time
10 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Neuron Specific Enolase (NSE) | ng/mL |
|
||
Test Version
19-Nov-2025
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| NSE S | 62968NEURON SPECIFIC ENOLASE (NSE), SERUM | ng/mL |
Test Version
19-Nov-2025